KRAS and colorectal carcinoma: Furthermore, our data provides an additional direct evidence that studies of the evolutionary trajectories of KRAS can have a strong clinical and prognostic impact also in discriminating between poly-metastatic aggressive vs oligo-metastatic indolent CRC subsets.